ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AHR vs MS // EV/EBITDA & P/E VALUATION

American Healthcare REIT Inc. (NYSE) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: AHR 7 — MS 4
▲ EV/EBITDA & P/E VALUATION LEADER: AHR
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHR VS. MS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AHR MS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 8.10% 3.00% +5.10 AHR /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 26.4x 31.0x -4.60 AHR /valuation <GO>
Free Cash Flow Yield 1.62% -7.25% +8.87 AHR /fcf-yield <GO>
Operating Margin 19.80% 24.60% -4.80 MS /operating-margins <GO>
Net Profit Margin 3.40% 20.20% -16.80 MS /net-margins <GO>
Revenue Growth (YoY) 11.20% 5.50% +5.70 AHR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 1.32% 2.21% -0.89 MS /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 5/9 +3.00 AHR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.7 51.0 +0.70 AHR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.11 1.04 +0.07 AHR /macro-sensitivity <GO>
Forward P/E Multiple — 16.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.34B $298.41B -$286.06B MS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AHR REV MS REV AHR GROSS % MS GROSS % AHR FCF MS FCF
FY 2025 $2.09B $0 — — $200.2M -$17.89B
FY 2024 $1.88B $0 — — $91.3M $1.36B
FY 2023 $1.67B $0 — — $23.4M -$33.54B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHR // BETA 1.11
MS // BETA 1.04